Na Xu
- Hematology top 2%
- Chronic Myeloid Leukemia Treatments 34
- Hematopoietic Stem Cell Transplantation 31
- Acute Myeloid Leukemia Research 31
- Genetics top 5%
- Chronic Lymphocytic Leukemia Research 18
- Myeloproliferative Neoplasms: Diagnosis and Treatment 9
- Mesenchymal stem cell research 8
-
- Acute Lymphoblastic Leukemia research 19
-
- Cytomegalovirus and herpesvirus research 10
- Cited by
- HematologyGeneticsOncology
- Journals
- Journal of Clinical Oncology (1 paper)SHILAP Revista de lepidopterología (1 paper)Blood (28 papers)
- Partner nations
- ChinaUnited StatesMyanmar
In The Last Decade
Na Xu
87 papers receiving 836 citations
Peers
Comparison fields: 5 of 72
- Hematology 560
- Genetics 220
- Oncology 215
- Immunology 150
- Public Health, Environmental and Occupational Health 194
Countries citing papers authored by Na Xu
This map shows the geographic impact of Na Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Na Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Na Xu more than expected).
Fields of papers citing papers by Na Xu
This network shows the impact of papers produced by Na Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Na Xu. The network helps show where Na Xu may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Na Xu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 4 | |
| 3 | 2025 | 1 | |
| 4 | 2024 | 2 | |
| 5 | 2024 | 1 | |
| 6 | 2023 | 0 | |
| 7 | 2023 | 0 | |
| 8 | 2022 | 6 | |
| 9 | 2022 | 5 | |
| 10 | 2021 | 8 | |
| 11 | 2020 | 18 | |
| 12 | 2020 | 12 | |
| 13 | 2019 | 1 | |
| 14 | 2017 | 0 | |
| 15 | 2017 | 1 | |
| 16 | 2017 | 1 | |
| 17 | 2017 | 42 | |
| 18 | 2016 | 19 | |
| 19 | 2016 | 8 | |
| 20 | 2016 | 3 |
About Na Xu
Na Xu is a scholar working on Hematology, Genetics and Public Health, Environmental and Occupational Health, having authored 98 papers that have together received 841 indexed citations. Recurring topics across this work include Chronic Myeloid Leukemia Treatments (34 papers), Hematopoietic Stem Cell Transplantation (31 papers), Acute Myeloid Leukemia Research (31 papers), Acute Lymphoblastic Leukemia research (19 papers), Chronic Lymphocytic Leukemia Research (18 papers), Cytomegalovirus and herpesvirus research (10 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (9 papers) and Mesenchymal stem cell research (8 papers). The work is most often cited by research in Hematology (560 citations), Genetics (220 citations) and Oncology (215 citations). Na Xu has collaborated with scholars based in China, United States and Myanmar. Frequent co-authors include Qifa Liu, Fen Huang, Zhiping Fan, Li Xuan, Jing Sun, Ren Lin, Jieyu Ye, Yu Wang, Xiao‐Jun Huang and Hongsheng Zhou. Their work appears in journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.